Strategic Consolidation in European HealthTech: Legrand Care’s Acquisition of Axel Health

Nelson Advisors
4 days ago
7 min read

Updated: 22 hours ago

Strategic Consolidation in European HealthTech: Legrand Care’s Acquisition of Axel Health

Transaction Architecture and Financial Overview

On July 29th, 2026, Legrand Care, the specialised connected healthcare technology division of French electrical and digital building infrastructure multinational Legrand SA, finalised the acquisition of Finnish digital patient flow management provider Axel Health Oy.

The transaction involved the complete buy-out of the equity stake held by Stockholm-based growth private equity firm Standout Capital, alongside minority holdings retained by key founders and management. Founded in 2008 and headquartered in Espoo, Finland, Axel Health has grown into a dominant provider of workflow software for acute public health networks, regional healthcare service authorities, and social care providers across the Nordic region.

Financial disclosures indicate that Axel Health generated pro forma revenues of approximately €9 million in fiscal year 2025, yielding an EBITDA between €2.5 million and €3.0 million. Standout Capital originally entered Axel Health via its Standout Capital I fund in May 2019. Over the course of Standout's seven-year investment lifecycle, Axel Health expanded its market leadership across Finland and Sweden, achieving a threefold increase in annual recurring revenue and a fourfold expansion in EBITDAC. This sustained expansion was achieved despite widespread structural budget constraints across European public health systems.

The transaction was structured as an all-cash strategic acquisition designed to allow rapid operational integration into Legrand Care's digital platform.

Sell-side M&A advisory was managed exclusively by MCF Corporate Finance, with a transaction team comprising Erik Pettersson, Robert Sällström, Johanna Tell, Amos Aaltio, and Jakob Scott. Legal representation for Axel Health and its selling equity holders was provided by Avance Attorneys.

Follow Nelson Advisors on LinkedIn https://www.linkedin.com/company/nelson-advisors

Transaction Parameter	Details & Financial Metrics	Sources
Transaction Close Date	July 29th, 2026	Various
Acquirer Entity	Legrand Care (Division of Legrand SA, Euronext Paris: LR)	Various
Target Entity	Axel Health Oy (Espoo, Finland)	Various
Seller Entity	Standout Capital (Standout Capital I Fund) & Minority Shareholders	Various
Transaction Structure	Undisclosed valuation; all-cash strategic buy-out	Various
Target FY25 Pro Forma Revenue	~€9.0 Million	Various
Target FY25 Pro Forma EBITDA	€2.5 Million – €3.0 Million	Various
Private Equity Value Creation (2019–2026)	3x Recurring Revenue Growth; 4x EBITDAC Growth	Various
Sell-Side M&A Advisor	MCF Corporate Finance	Various
Sell-Side Legal Counsel	Avance Attorneys	Various

Target Platform Capabilities: Axel Health’s Patient Flow Ecosystem

Axel Health operates as a software provider with a team of approximately 46 employees across Finland and Sweden. Its technological architecture addresses operational bottlenecks in high-density medical environments, including major university hospitals, primary health clinics, emergency care centers, and specialised outpatient facilities. Axel Health's primary value proposition centres on eliminating physical administrative queues, maximising facility usage rates, and automating patient transition communication between care settings.

The company's core platform is organised into three interconnected software environments that digitise the patient journey:

Axel Encounter forms the frontend engagement and check-in architecture. Operating via self-service touch-screen kiosks, mobile devices, and digital signage, Encounter handles patient check-in, real-time wayfinding, clinical questionnaire collection, and payment processing. The system reduces patient check-in routines to an average of 17 seconds, achieving administrative automation rates exceeding 90% and alleviating reception desk congestion. In paediatric clinical settings, Encounter incorporates customised features such as digital avatar guides to lower stress levels for young patients.

Axel Planner functions as the centralised shift management, facility scheduling and operational planning engine. Planner merges room-booking requirements across disparate medical units into a single synchronised interface, preventing scheduling conflicts and optimising clinical space usage. By matching clinical staff shift patterns against forecasted patient visit volumes, Planner reduces administrative overhead for doctors, nurses and unit secretaries.

Uoma operates as a patient transfer coordination module. Originally developed by Unitary Healthcare Oy and acquired by Axel Health in mid-2024, Uoma replaces unstructured telephone communications with real-time location tracking and structured digital messaging during patient transfers. The software accelerates placement identification for follow-up care, facilitating smoother transfers between acute care hospitals and municipal social services.

Software Module	Core Functionality	Primary Operational Impact
Axel Encounter	Self-service kiosks, mobile check-in, digital wayfinding, payment automation, pediatric avatars	Reduces check-in times to 17 seconds; achieves >90% administrative automation rate
Axel Planner	Resource allocation, shift optimization, shared room scheduling, spatial analytics	Eliminates overlapping facility bookings; optimizes staff allocation against patient volume
Uoma	Inter-unit patient transfer coordination, structured messaging, placement tracking	Removes phone communication bottlenecks; accelerates transition from acute to social care
Platform Ecosystem	Unified patient journey execution suite	Delivers >20% savings in personnel costs; generates up to 4.5x return on software investment

Corporate Transformation: Legrand Care’s M&A Strategy

Legrand Care operates as the dedicated healthtech and assisted living division of Legrand SA, an industrial

group with global revenues of €6.1 Billion in 2020 and operations in over 90 countries. Legrand Care was formally created in November 2021 under CEO Chris Dodd, bringing together five established European telecare and health technology providers: Aid Call, Tynetec, Jontek (United Kingdom), Neat (Spain/Sweden), and Intervox (France). Executive management was further consolidated with Arturo Pérez Kramer as Deputy CEO and Caroline Mouminoux as Sales Director.

Historically focused on physical infrastructure, including wireless nurse call hardware (Touchsafe Pro), alarm monitoring platforms (Answerlink) and connected telecare hubs (NOVO and NOVO Go), Legrand Care has faced shifting dynamics in European healthcare. Structural demographic aging, rising chronic disease prevalence and nursing shortages across Europe have driven demand away from standalone hardware devices toward cloud-native software ecosystems capable of managing care coordination across home, residential and hospital environments.

To address these market demands, Legrand Care launched a programmatic M&A sequence across Europe:

In 2024, Legrand Care acquired Dutch digital care platform Enovation from Main Capital Partners. Enovation provided foundational capabilities in clinical data integration, inter-professional messaging, and secure healthcare communication infrastructure.

In 2025, Legrand Care acquired Netherlands-based health analytics provider Performation from Gilde Healthcare. Performation contributed business intelligence tools, healthcare delivery analytics, and operational planning software.

The 2026 acquisition of Axel Health represents the third major transaction in this expansion sequence. Axel Health supplies the patient-facing engagement layer, real-time hospital patient flow management and inter-unit transfer coordination that links hospital operations directly with community care infrastructure.

Strategic Asset	Acquisition Year	Divesting Entity	Strategic Capabilities Added	Source
Enovation	2024	Main Capital Partners	Secure clinical data integration, inter-professional communication, healthcare interoperability	Various
Performation	2025	Gilde Healthcare	Healthcare business intelligence, operational analytics, financial optimization platforms	Various
Axel Health	2026	Standout Capital	Real-time patient flow management (PFM), automated scheduling, patient transfer systems	Various

Strategic Rationale and Ecosystem Synergies

The integration of Axel Health into Legrand Care delivers strategic advantages across market expansion, product cross-selling, and competitive positioning:

The Nordic region represents one of Europe's most digitally mature public healthcare markets, characterised by single-payer structures, widespread Electronic Health Record adoption, and high public health investments. Axel Health maintains deep customer relationships across Finnish Wellbeing Services Counties and Swedish healthcare regions. Acquiring Axel Health gives Legrand Care an established commercial network to cross-sell its wider software portfolio across Northern Europe.

A primary friction point in European healthcare delivery occurs during patient transitions between acute hospital care, post-acute rehab, and home care. Uncoordinated transfer processes often lead to extended hospital stays and bed-blocking. Integrating Axel Health’s Uoma transfer tracking and Planner resource tools with Enovation’s messaging hub and Legrand Care’s NOVO Go home monitoring devices creates a unified care management pathway. Hospital discharge planners can schedule a patient's transition home, order post-discharge social care services, and provision remote telecare monitoring within a single workflow.

Combining building electrical infrastructure, nurse call hardware, clinical integration software, and patient flow management positions Legrand Care more directly against healthcare conglomerates like Philips Healthcare Solutions and Siemens Healthineers. While traditional competitors focus primarily on medical devices or basic building management, Legrand Care offers an enterprise platform bridging physical infrastructure with healthcare software.

Executive commentary confirms this strategic alignment. Chris Dodd, CEO of Legrand Care, highlighted that Axel Health has established a strong position in patient flow management that complements Legrand Care's digital platform. Ilari Laaksonen, CEO of Axel Health, noted that joining Legrand Care presents opportunities for customers, employees, and partners by accelerating the development of patient flow and engagement software within a global corporate organisation. Erik Wästlund, Co-founder of Standout Capital, emphasised that the company's financial growth during Standout's ownership period demonstrates the underlying market demand for workflow optimisation tools.

Post-Merger Integration Dynamics and Risk Landscape

Realising the expected return on investment will require active management of several post-merger integration risks:

Harmonising Axel Health’s technology stack with the existing Enovation and Performation software platforms requires ongoing development work. Establishing standardised Application Programming Interfaces (APIs) and unified data models is necessary to enable real-time communication between Axel Encounter check-in kiosks, Axel Planner booking engines, Enovation clinical messaging hubs, and Answerlink monitoring platforms.

Expanding Axel Health’s platform outside its core Nordic markets into the United Kingdom, France and Central Europe introduces regulatory and localisation challenges. Healthcare purchasing structures, patient privacy laws and hospital operational models vary significantly across European jurisdictions. Legrand Care must adapt Axel Health's software to meet local regulatory frameworks and integration standards without incurring excessive customisation costs.

Preserving Axel Health’s customer-centric culture and agile product iteration speed while integrating into a large industrial enterprise represents a key organizational objective. Management must maintain key engineering talent and safeguard software development velocity to ensure the business remains competitive against specialised healthtech vendors.

Outlook and Industry Implications

Legrand Care’s acquisition of Axel Health reflects a broader ongoing consolidation trend within the European HealthTech market. As public healthcare systems grapple with demographic pressure, fiscal constraints, and staffing challenges, demand is accelerating for software platforms that improve operational productivity, shorten patient stay durations, and streamline administrative workflows.

By successfully uniting physical infrastructure, telecare hardware, and a connected software stack comprising Enovation, Performation, and Axel Health, Legrand Care has established an integrated care management platform. This transaction positions the company to capture growing market share across European healthcare and social care sectors as health authorities increasingly transition toward unified, technology-enabled care ecosystems.

Nelson Advisors > European HealthTech, MedTech, Digital Health Investment Banking

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, MedTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies.www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Thought Leadership articles covering market insights, industry trends, deal commentary, market analysis & predictions @ https://www.healthcare.digital

Nelson Advisors publish Europe's Leading Healthcare Technology Investment Banking Newsletter every week, join 5000+ HealthTech and MedTech subscribers today! https://lnkd.in/e5hTp_xb

Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards, corporates, venture capital and private investors to maximise shareholder value and investment returns.www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #MedTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #FemTech #ConsumerHealth #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #Canada #Commonwealth #CorporateDivestitures #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics